Coronary Calcium, ApoB, and Lp(a): Questions to Ask a Preventive Cardiologist in 2026

The 2026 American College of Cardiology and American Heart Association dyslipidemia guideline emphasizes cardiovascular risk estimation, individualized discussion of treatment, and thoughtful use of additional tests to refine prevention plans.

Lipoprotein(a), commonly called Lp(a), is largely inherited. The 2026 guideline recommends that adults have an Lp(a) measurement at least once as part of atherosclerotic cardiovascular risk assessment.

Apolipoprotein B, or ApoB, can help with selected questions about atherogenic particle burden, particularly in people with metabolic risk factors, elevated triglycerides, diabetes, or discordant standard lipid results. Your clinical context determines whether testing would add value.

Coronary artery calcium scoring may help guide treatment decisions for selected adults whose risk and lipid treatment decisions remain uncertain. The guideline identifies men aged at least 40 years and women aged at least 45 years in relevant risk groups as potential candidates for selective CAC assessment. A score of zero requires interpretation alongside family history, smoking, diabetes, and other important risk factors.

A preventive cardiology consultation can integrate cardiovascular risk factors, available imaging, blood pressure, family history, medications, and your goals into a tailored plan. Additional testing should be clinically indicated and may involve separate laboratory or imaging charges.

Read the professional guideline overview at https://professional.heart.org/en/science-news/2026-guideline-on-the-management-of-dyslipidemia. For a personalized virtual review, request an appointment with My Heart Spark P.C. at https://myheartspark.clientsecure.me/.

This information supports education and shared clinical decision making. Urgent symptoms require prompt local medical evaluation.